Mobile

A study to evaluate whether a new inhaled medicine (combination of beclometasone plus formoterol plus glycopyrronium) works as well as a licensed medicine (combination of indacaterol and glycopyrroniu...

Update Il y a 4 ans
Reference: EUCTR2014-001704-22

A study to evaluate whether a new inhaled medicine (combination of beclometasone plus formoterol plus glycopyrronium) works as well as a licensed medicine (combination of indacaterol and glycopyrronium) in patients with chronic obstructive pulmonary disease

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To demonstrate the superiority of CHF 5993 pMDI over Ultibro® in terms of moderate and severe COPD exacerbation rate over 52 weeks of treatment.

Inclusion criteria

  • Chronic Obstructive Pulmonary Disease

Links